Trials / Completed
CompletedNCT03801382
Psychometric Properties of IntelliSpace Cognition
Study to Establish the Psychometric Properties of the Digital Cognitive Tests on the Philips IntelliSpace Cognition Platform
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 450 (actual)
- Sponsor
- Philips Electronics Nederland B.V. acting through Philips CTO organization · Industry
- Sex
- All
- Age
- 50 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
This study aims to validate the tests that are on the IntelliSpace Cognition platform and to establish normative data for these tests.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | IntelliSpace Cognition (ISC) | Philips ISC is a Class-II Medical Device in the US and provides objective data regarding cognition via scoring algorithms that HCPs can use to inform diagnostic decision making and treatment planning. It enables tracking cognition over time and offers the possibility of new outcome measures. ISC can be used in a variety of healthcare environments such as neurology and neuropsychology practices. |
| DIAGNOSTIC_TEST | Paper-Pencil Tests | The same cognitive tests that are on the ISC platform are performed using paper and pencil (rather than digitally) as is the case in standard clinical practice. |
Timeline
- Start date
- 2019-04-15
- Primary completion
- 2019-08-26
- Completion
- 2019-08-26
- First posted
- 2019-01-11
- Last updated
- 2023-06-22
- Results posted
- 2023-06-22
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03801382. Inclusion in this directory is not an endorsement.